Epidemiologic cohort study for partial lipodystrophy following hematopoietic stem cell transplantation

Epidemiologic cohort study for partial lipodystrophy following hematopoietic stem cell transplantation - lipodystrophy related with hematopoietic stem cell transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013087

Enrollment

Registered

2014-02-10

Start date

2014-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent HSCT as a treatment for childhood cancer and are in remission

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Estimation of the incidence, time of onset, and the pattern of development of partial lipodystrophy in CCS patients following HSCT.	—

Secondary

Measure	Time frame
1. Identification of risk factor(s) for developing partial lipodystrophy following HSCT 2. Investigation of the relationship between partial lipodystrophy and fatty liver 3. Estimation of the incidence of dyslipidemia and impaired glucose tolerance in CCS patients following HSCT	—

Countries

Japan

Contacts

Public ContactSatoshi Nakajima

Kanagawa Children&#39;s Medical Center Executive office of Ethical Committee

nakajima.13011@kanagawa-pho.jp+81-45-711-2351

Outcome results